Most venture capital funds claim to engage in “active management,” while in fact, doing little more than assuming passive board roles. AIM-HI will be actively involved in all portfolio companies…
At the end of the competition, there will be two awardees – winner and runner-up. The awardees will receive up to $25,000 from AIM-HI as cash prize and being accepted into the Accelerator program…
We estimate that the U.S. spends about USD 20 billion a year on cancer research, but only 0.5 percent of that goes toward translating research out of the lab and into the real world, where it can change and save lives.
Our Mission
The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients’ lives.
Portfolio Companies
AIM-HI Women Bioentrepreneurs Venture Competition - win up to $300,000 in seed funding!
